Novel Protective Effects of Histone Deacetylase Inhibition on Stroke and White Matter Ischemic Injury

Neurotherapeutics

Volumn 10, Issue 4, 2013, Pages 798-807

  Baltan, Selva ^a   Morrison, Richard S ^b   Murphy, Sean P ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

aging; Cerebral ischemia; infarct; mitochondria; p53; Zn dependent histone deacetylase

Indexed keywords

BUTYRIC ACID; GIVINOSTAT; GLUCOSE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; OXYGEN; PROTEIN P53; SHORT HAIRPIN RNA; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN ISCHEMIA; CANCER THERAPY; CELL DEATH; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EPIGENETICS; GLIA; LIVER MITOCHONDRION; MOUSE; NERVE CELL; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WHITE MATTER INJURY;

AXONS; BRAIN ISCHEMIA; CELL DEATH; HISTONE DEACETYLASE INHIBITORS; HUMANS; NERVE FIBERS, MYELINATED; NEURONS; NEUROPROTECTIVE AGENTS; STROKE;

EID: 84886300259     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-013-0201-x     Document Type: Review

References (62)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update. Circulation 2013;127: e6-e245.
2. Sun J, Sun J, Ming G-l, Song H. Epigenetic regulation of neurogenesis in the adult mammalian brain. Europ J Neurosci 2011;33: 1087-1093.
3. Qureshi IA, Mehler MF. The emerging role of epigenetics in stroke. III Neural stem cell biology and regenerative medicine. Arch Neurol 2011;68: 294-302.
4. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17: 330-339.
5. Pearce WJ. Epigenetics: an expanding new piece of the stroke puzzle. Transl Stroke Res 2011;2: 243-247.
6. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res 2010;1338: 20-35.
7. Dharap A, Nakka VP, Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke 2012;43: 2800-2802.
8. Kaur P, Liu F, Rong et al. Non-coding RNAs as potential neuroprotectants against ischemic brain injury. Brain Sci 2013;3: 360-395.
9. Qureshi IA, Mehler MF. The emerging role of epigenetics in stroke II. RNA regulatory circuitry. Arch Neurol 2010;67: 1435-1441.
10. Liu D-Z, Tian Y, Ander BP et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures J Cereb Blood Flow Metab 2010;30: 92-101.
11. Ouyang YB, Stary CM, Yang GY, Giffard R. MicroRNAs: Innovative targets for cerebral ischemia and stroke. Curr Drug Targets 2013;14: 90-101.
12. Wang Y, Wang Y, Yang G-Y. MicroRNAs in cerebral ischemia. Stroke Res Treat 2013 ID 276540.
13. Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol Genom 2011;43: 521-528.
14. Qureshi IA, Mehler MF. Emerging role of epigenetics in stroke. Part 1: DNA methylation and chromatin modifications. Arch Neurol 2010;67: 1316-1322.
15. Baltan S, Bachleda A, Morrison RS, Murphy SP. Expression of histone deacetylases in cellular compartments of the mouse brain and the effects of ischemia. Trans Stroke Res 2011;2: 411-423.
16. Baltan S, Besancon EF, Mbow B, Ye, ZC, Hamner M, Ransom BR. White matter vulnerability to ischemic injury increases with age due to enhanced excitotoxicity. J Neurosci 2008;28: 1479-1489.
17. Gibson CL, Murphy SP. Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem 2010;115: 806-813.
18. Wang Z, Leng Y, Tsai L-K, Leeds P, Chuang D-M. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 2011: 31;52-57.
19. Wang B, Zhu X, Kim YT, et al. HDAC inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Rad Biol Med 2012;52: 928-936.
20. He M, Zhang B, Wei X, Wang Z, Fan B, Du P, et al. HDAC4/5-HMGB1 signaling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. J Cell Mol Med 2013;17: 531-542:.
21. Del Zoppo GJ. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J Intern Med 1995;237: 79-88.
22. Del Zoppo GJ. Clinical trials in acute stroke: why have they not been successful? Neurology 1998;51: S59-S61.
23. Dirnagl U, Iadecola C, Moskowitz MA Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22: 391-397.
24. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006;59: 467-477.
25. Cavallotti C, Pacella E, Pescosolido N, Tranquilli-Leali FM, Feher J. Age-related changes in the human optic nerve. Can J Ophthalmol 2002;37: 389-394.
26. Cavallotti C, Cavallotti D, Pescosolido N, Pacella E. Age-related changes in rat optic nerve: morphological studies. Anat Histol Embryol 2003;32: 12-16.
27. Baltan S, Murphy SP, Danilov AC, Bachleda A, Morrison R. Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity. J Neurosci 2011;31: 3990-3999.
28. Baltan S. Histone deacetylase inhibitors preserve function in aging axons. J Neurochem 2012;123(Suppl. 2): 108-115.
29. Baltan S. Ischemic injury to white matter: An age-dependent process. Neuroscientist 2009;15: 126-133.
30. Tekkok SB, Ye ZC, Ransom BR. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007;27: 1540-1552.
31. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16: 675-686.
32. Acheson A, Conover JC, Fandl JP, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995;374: 450-453.
33. Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 2001;24: 677-736.
34. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psych 2009;14: 51-59.
35. Liu XS, Chopp M, Kassis H, et al. Valproic acid increases white matter repair and neurogenesis after stroke. Neuroscience 2012;220: 313-321.
36. Wang Z, Tsai LK, Munasinghe J, et al. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke 2012;43: 2430-2436.
37. Fass DM, Reis SA, et al. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity. Neuropharmacology 2013;64: 81-96.
38. Chen SH, Wu HM, Ossola B, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol 2012;165: 494-505.
39. Martín-Montalvo A, Villalba JM, Navas P, de Cabo R. NRF2, cancer and calorie restriction. Oncogene 2011;30: 505-520.
40. Son TG, Camandola S, Arumugam TV, et al. Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 2010;112: 1316-1326.
41. Morrison R, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53-dependent cell death signaling in neurons. Neurochem Res 2003;28: 15-27.
42. Uo T, Kinoshita Y, Morrison RS. Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons. J Neurosci 2007;27: 12198-12210.
43. Langley B, D'Annibale MA, Suh K, et al. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21waf1/cip1 in cell cycle-independent neuroprotection. J Neurosci 2008;28: 163-176.
44. Chen S, Owens GC, Makarenkova H, Edelman DB. HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One 2010;5: e10848.
45. Dompierre JP, Godin JD, Charrin BC, Cordelières FP, et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 2007;27: 3571-3583.
46. Kim JY, Shen S, Dietz K, He Y, Reynolds R, Casaccia P. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 2010;13: 180-189.
47. Wang DB, Garden GA, Kinoshita C, et al. Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. J Neurosci 2013;33: 1357-1365.
48. Uo T, Veenstra TD, Morrison RS. HDAC inhibitors prevent p53-dependent and -independent Bax-mediate neuronal apoptosis through two distinct mechanisms. J Neurosci 2009;29: 2824-2832.
49. Marinova Z, Ren M, Wendland JR, Leng Y, et al. Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. J Neurochem 2009;111: 976-987.
50. Leng Y, Liang MH, Ren M, et al. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 2008;28: 2576-2588.
51. Bolger TA, Yao TP. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci 2005;25: 9544-9553.
52. Yang Y, Qin X, Liu S, et al. Peroxisome proliferator-activated receptor γ is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J Neurochem 2011;118: 429-439.
53. Kahle MP, Bix GJ. Neuronal restoration following ischemic stroke: influences, barriers, and therapeutic potential. Neurorehabil Neural Repair 2013;27: 469-478.
54. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004;101: 16659-16664.
55. Balasubramaniyan V, Boddeke E, Bakels R Effects of HDAC inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006: 143; 939-951.
56. Dovey OM, Foster CT, Cowley SM. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci U S A 2010;107: 8242-8247.
57. Lee S, Lee S-K. Crucial roles of histone-modifying enzymes in mediating neural cell-type specification. Curr Opin Neurobiol 2010;20: 29-36.
58. Montgomery RL, Hsieh J, Barbosa AC, Richardson JA, Olson EN. HDACs 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci U S A 2009;106: 7876-7881.
59. Humphrey GW, Wang Y-H, Hirai T, et al. Complementary roles for HDACs 1, 2, and 3 in differentiation of pluripotent stem cells. Differentiation 2008;76: 348-356.
60. Kim H J, Rowe M, Ren M, Hong J-S, Chen P-S, Chuang D-M. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007;321: 892-901.
61. Guan J-S, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009;459: 55-60.
62. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-nitrosylation of HDAC2 induces chromatin remodeling in neurons. Nature 2008;455: 411-415.